Atherosclerosis
Volume 183, Issue 1 , Pages 25-33 , November 2005

Macrophage-foam cell formation in streptozotocin-induced diabetic mice: Stimulatory effect of glucose

  • Tony Hayek

      Affiliations

    • The Lipid Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion, The Rappaport Family Institute for Research in the Medical Sciences and Internal Medicine Department ‘E’, Rambam Medical Center, 31096 Haifa, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972 4 854 2059; fax: +972 4 854 2359.
    • ,
  • Khitam Hussein

      Affiliations

    • The Lipid Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion, The Rappaport Family Institute for Research in the Medical Sciences and Internal Medicine Department ‘E’, Rambam Medical Center, 31096 Haifa, Israel
    • ,
  • Michael Aviram

      Affiliations

    • The Lipid Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion, The Rappaport Family Institute for Research in the Medical Sciences and Internal Medicine Department ‘E’, Rambam Medical Center, 31096 Haifa, Israel
    • ,
  • Raymond Coleman

      Affiliations

    • The Department of Anatomy and Cell Biology, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
    • ,
  • Shlomo Keidar

      Affiliations

    • The Lipid Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion, The Rappaport Family Institute for Research in the Medical Sciences and Internal Medicine Department ‘E’, Rambam Medical Center, 31096 Haifa, Israel
    • ,
  • Elsa Pavoltzky

      Affiliations

    • The Lipid Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion, The Rappaport Family Institute for Research in the Medical Sciences and Internal Medicine Department ‘E’, Rambam Medical Center, 31096 Haifa, Israel
    • ,
  • Marielle Kaplan

      Affiliations

    • The Lipid Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion, The Rappaport Family Institute for Research in the Medical Sciences and Internal Medicine Department ‘E’, Rambam Medical Center, 31096 Haifa, Israel

Received 8 July 2004 ,Revised 31 December 2004 ,Accepted 7 February 2005.

References 

  1. Bierman EL. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb. 1992;12:647–656
  2. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery diseases in juvenile-onset, insulin dependent diabetes mellitus. Am J Cardiol. 1987;59:750–755
  3. Fisher M. Diabetes and atherogenesis. Heart. 2004;90(3):336–340
  4. Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108(12):1527–1532
  5. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952–957
  6. Santini SA, Marra G, Giardina B, et al. Defective plasma antioxidants defenses and enhanced susceptibility to lipid peroxidation in uncomplicated NIDDM. Diabetes. 1997;46:1853–1858
  7. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms: oxidation, inflammation and genetics. Circulation. 1995;91:2488–2496
  8. Aviram M. Interaction of Ox-LDL with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem. 1996;34:599–608
  9. Kaplan M, Aviram M. Ox-LDL atherogenic and proinflammatory characteristics during macrophage foam cell formation:an inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med. 1999;37:777–787
  10. Kunjachoor VV, Wilson DL, Le Boeuf R. Increased atherosclerosis in streptozocin-induced diabetic mice. J Clin Invest. 1996;97:1767–1773
  11. Levi Z, Shaish A, Yacov N, et al. Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model. Diabetes Obes Metab. 2003;5:45–50
  12. Candido R, Jandeleit-Dahm KA, Cao Z, et al. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation. 2002;106(2):246–253
  13. Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab. 2002;282(1):E207–E214
  14. Kislinger T, Tanji N, Wendt T, et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2001;21(6):905–910
  15. Fukuhara-Takaki K, Sakai M, Sakamoto YI, Takeya M, Horiuchi S. Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo; one mechanism for an increased rate of atherosclerosis in diabetes. J Biol Chem. 2005;280(5):3355–3364
  16. Lin RY, Choudhury RP, Cai W, et al. Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 2003;168(2):213–220
  17. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5(5):561–568
  18. Wendt T, Bucciarelli L, Qu W, et al. Receptor for advanced glycation end products and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep. 2002;4(3):228–237
  19. Forbes JM, Yee LT, Thallas V, et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes. 2004;53(7):1813–1823
  20. Park L, Raman KG, Lee KJ, et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end-products. Nat Med. 1998;4(9):1025–1031
  21. Laakso M, Muusisto J. Epidemiological evidence for the association of hyperglycemia and atherosclerotic vascular disease in non-insulin dependent diabetes. Ann Med. 1996;28:415–418
  22. Maziere C, Auclair M, Rose-Robert F, Leflon P, Maziere JC. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. FEBS Lett. 1995;363(3):277–279
  23. Griffin E, Re A, Hamel N, et al. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med. 2001;7(7):840–846
  24. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in E0 mice created by homologous recombination in ES cells. Cell. 1992;71:343–353
  25. Fuhrman B, Shiner M, Volkova N, Aviram M. Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation. Free Radical Biol Med. 2004;37:259–271
  26. Aviram M, Rosenblat M, Bisgaier CL, et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest. 1998;101:1581–1590
  27. Maor I, Kaplan M, Hayek T, et al. Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from E0 mice and from human carotid artery contain lipid peroxides and oxysterols. Biochem Biophys Res Commun. 2000;269:775–780.
  28. Johnston RB, Keele BB, Mirsa HP, et al. The role of superoxide anion generation in phagocytic bactericidal activity. J Clin Invest. 1975;55:1357–1372
  29. Li Y, Zhu H, Kuppusamy P, et al. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem. 1998;173:2015–2023
  30. Yanagitani Y, Rakugi H, Okamura A, et al. Angiotensin-II type-1 receptor-mediated peroxide production in human macrophages. Hypertension. 1999;33:335–339
  31. Goldstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983;98:241–260
  32. Hayek T, Kaplan M, Raz A, et al. Ramipril administration to atherosclerotic mice reduces oxidized LDL uptake by their macrophages and blocks the progression of atherosclerosis. Atherosclerosis. 2002;161:65–74
  33. Musson RA. Human serum induces maturation of human monocytes invitro: changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol. 1983;111:331–340
  34. Hayek T, Kaplan M, Raz A, et al. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis. Atherosclerosis. 2002;161:65–74
  35. Tse J, Martin-McNaulty B, Halks-Miller M, et al. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male E0 mice can be prevented by chronic treatment with 17-beta-estradiol. Atherosclerosis. 1999;144(2):303–313
  36. Keidar S, Kaplan M, Aviram M. Angiotensin-II modified LDL is taken up by macrophages via the scavenger receptor leading to cellular cholesterol accumulation. Arterioscler Thromb Vasc Biol. 1996;16:122–129
  37. Kellner-Weibel G, Yancey PG, Jerome WG, et al. Crystallization of free cholesterol in model macrophage foam cells. Arterioscler Thromb Vasc Biol. 1999;19:1891–1898
  38. Zhang L, Zalewski A, Liu Y, et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation. 2003;108:472–478
  39. Han J, Hajjar DP, Febbraio M, Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor. J Biol Chem. 1997;272:21645–21659
  40. Fuhrman B, Volkova N, Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis. 2002;161(2):307–316
  41. Febbraio M, Podrez EA, Smith JD, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000;105(8):1049–1056
  42. Iwashima Y, Eto M, Hata A, et al. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages. Biochem Biophys Res Commun. 2000;277(2):368–380

PII: S0021-9150(05)00161-9

doi: 10.1016/j.atherosclerosis.2005.02.018

Atherosclerosis
Volume 183, Issue 1 , Pages 25-33 , November 2005

Article Tools

* Image Usage & Resolution